Healthy
Celex Oncology Innovations Limited·11085607
No distress signals. Accounts cover the period ending 31 Dec 2024.
CELEX ONCOLOGY INNOVATIONS LIMITED·Company no. 11085607·United Kingdom
The Firmwatch take
Celex Oncology Innovations Limited is a 8-year-old SIC 21100 company, active on the Companies House register. The latest filed accounts (year to 31 December 2024) show GBP 2.3m in net assets, with no distress signals detected. No insolvency or strike-off filings appear in our public Companies House and Gazette data.
Refreshed 24 May 2026
Incorporated
28 November 2017
8 years on the register
Sector
Pharmaceutical manufacturing
SIC 21100 · matched to division
Size
Not classified
Net assets
£2.3m
£2,289,508
Cash at bank
Not disclosed
Not required for this filing type
Latest filing
None yet
Firmwatch turns UK Companies House filings into plain-English company intelligence. Data is refreshed daily; signals are generated from public balance-sheet and filing patterns.
Directors
director · appointed 28 Nov 2017
GEMMABEL LIMITED
active
BARKING CENTRAL MANAGEMENT COMPANY (NO.2) LIMITED
active
CAROLINE COURT 2020 LIMITED
active
CELEX HOLDINGS LIMITED
dissolved
AWOL LONDON LIMITED
active
CELEX ONCOLOGY LIMITED
dissolved
EDGE PETROL LIMITED
active
DIATECH ONCOLOGY TPA LIMITED
active
LONGACRE FUNDING LIMITED
dissolved
PIERIAN BIOSCIENCES LIMITED
active
director · appointed 21 Jul 2019
director · appointed 26 Aug 2024
Persons with Significant Control
individual person with significant control
significant influence or control
Notified 25 Sept 2019
individual person with significant control
Shares 25 to 50 percent, Voting rights 25 to 50 percent
Notified 28 Nov 2017
individual person with significant control
Shares 25 to 50 percent, Voting rights 25 to 50 percent
Notified 28 Nov 2017